The Biden administration made headlines on 5 May when, in a sharp reversal of US policy, it accounted its agreement, in principle, with proposals at the WTO to waive patent protection for COVID-19 vaccines. Pharma companies and stockbrokers were not the only ones taken by surprise by the US volte-face. Other Western States where COVID-19 vaccines are produced, especially in …